Why did Visa (NYSE:V) acquire BioCatch?

Visa (NYSE:V) acquired BioCatch to expand its existing suite of fraud and cybersecurity products. The company stated the $2.4 billion acquisition will strengthen its ability to protect consumers from financial crime and account takeovers before they reach the point of payment.

How does BioCatch detect fraud?

BioCatch monitors behavioral cues to tell genuine account holders apart from bad actors as transactions occur. Its AI and machine-learning models collect more than 3,000 anonymized data points per session, such as how users type, swipe, and hold their devices.

What is the customer base for BioCatch?

BioCatch serves more than 350 banks across 21 countries, including over 100 of the world's largest financial institutions. Its network coverage extends to 1.8 billion devices and 760 million individual users.

When is the Visa (NYSE:V) acquisition of BioCatch expected to close?

The transaction is contingent on customary regulatory approvals. Visa (NYSE:V) expects to complete the acquisition of BioCatch no later than the final weeks of its fiscal second quarter of 2027.

How is Visa (NYSE:V) funding its value-added services division?

Visa (NYSE:V) is currently restructuring its workforce, cutting roughly 2,600 jobs. The company expects freed-up capital from these cuts to flow into areas like its value-added services division, which encompasses the BioCatch acquisition.

Image for illustrative purposes only. Not a real photo.

Visa to buy BioCatch for $2.4 billion

Written by Liezl GambePublished Aug 3, 2026, 4:00 AM

Visa agreed to acquire the AI-powered fraud detection firm BioCatch in an all-cash transaction valued at $2.4 billion.
The acquisition directly expands Visa's existing cybersecurity suite and its broader value-added services division.
The company stated the deal will strengthen its ability to protect consumers from financial crime and account takeovers.

Visa (NYSE: V) agreed to acquire the AI-powered fraud detection firm BioCatch for $2.4 billion in cash.

This transaction follows Visa's earlier investment of over $13 billion toward technology and infrastructure upgrades over the preceding five years.

"BioCatch will help our clients stop fraud before it reaches the point of payment," said Visa President of Value-Added Services Andrew Torre.

The acquisition targets completion no later than the final weeks of Visa's fiscal second quarter of 2027, pending regulatory approval.

Following the announcement, Visa's share price was up at $368.33.

The payments company announced the acquisition amid a broader corporate restructuring that involves cutting roughly 2,600 jobs, or 7% of its workforce.

Freed-up capital from those workforce reductions is expected to flow into divisions like value-added services, which encompasses the newly acquired BioCatch business.

Visa to buy BioCatch for $2.4 billion

Frequently asked questions

Assets related to this article